Tramadol Reclassification: What it means to you
As of August 18, 2014, tramadol and products containing tramadol will be classified as Schedule IV. Tramadol is an opioid analgesic used to treat moderate to moderately severe pain and is sometimes prescribed by oral surgeons for patients recovering from oral surgery. According to the DEA, a Schedule IV drug is a drug with a low potential for abuse and low risk of dependence. Examples of Schedule IV drugs are Valium, Ativan, Ambien and Xanax.
Please take a moment to read the following information related to the reclassification of tramadol provided by the Pharmacy Quality Assurance Commission:
All pharmacies and any persons who handle- manufacture, distribute, dispense, import, export, engage in research, conduct instructional activities with or possess- tramadol, must take an inventory of their current stock of tramadol and other products containing tramadol on August 18, 2014.
Any location possessing tramadol or products containing tramadol that is not currently registered with US Drug Enforcement Agency (DEA) must apply for and receive a DEA registration prior to August 18, 2014. Alternatively, those locations not wishing to seek DEA registration must remove all tramadol products from their possession prior to August 18, 2014.
All current prescriptions for tramadol and products containing tramadol must be treated as controlled substance prescriptions on and after August 18, 2014.
Prior to filling/refilling a tramadol prescription on or after August 18, 2014, ensure that the prescriber has a valid DEA registration, as required for all controlled substance prescriptions. All prescribers who do not have a valid DEA registration will not be able to issue prescriptions or personally furnish tramadol or tramadol containing products.
If a prescription for a tramadol product was issued prior to August 18, 2014 and refills were authorized, as of August 18, 2014 those refills must be limited to no more than five and must be dispensed no later than six months after the date the prescription was initially issued.
No electronic prescriptions for tramadol or products containing tramadol may be sent to a pharmacy using an electronic prescription transmission system unless the prescriber’s and the receiving pharmacy’s systems meet the DEA authenticated system requirements addressed in 21 CFR 1311.
Click here for more information regarding tramadol